Press release
Non-invasive prenatal testing (NIPT) Market Size, Growth, Opportunities 2024-2032 | Illumina, Inc, YOURGENE HEALTH, Natera, Hoffmann-La Roche Ltd, PerkinElmer Inc., Laboratory Corporation of America, Eurofins LifeCodexx GmbH
Non-invasive prenatal testing (NIPT) is a method used to assess the risk of certain genetic conditions in a fetus early in pregnancy. This advanced testing technique analyzes small fragments of fetal DNA that are present in the mother's bloodstream. NIPT is primarily used to screen for chromosomal abnormalities such as Down syndrome, trisomy 18, and trisomy 13, as well as certain chromosome abnormalities.The key advantage of NIPT is its non-invasive nature, meaning it poses no risk to the fetus compared to invasive procedures like amniocentesis or chorionic villus sampling (CVS), which involve taking samples from the amniotic fluid or placenta. NIPT can be performed as early as the 10th week of pregnancy and typically offers high sensitivity and specificity for detecting chromosomal abnormalities, making it a popular choice among expectant parents for prenatal screening. However, it is important to note that NIPT is a screening test and not a diagnostic test; positive results may require follow-up with diagnostic testing to confirm any conditions.
๐๐ถ๐๐ฐ๐ผ๐๐ฒ๐ฟ ๐ช๐ต๐ฎ๐ ๐ฌ๐ผ๐'๐ฟ๐ฒ ๐ ๐ถ๐๐๐ถ๐ป๐ด: ๐๐ฒ๐ ๐ฎ ๐๐ฟ๐ฒ๐ฒ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ (๐ฃ๐๐) ๐ฆ๐ฎ๐บ๐ฝ๐น๐ฒ: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/non-invasive-prenatal-testing-market-100998
๐๐ฒ๐ ๐๐ป๐ฑ๐๐๐๐ฟ๐ ๐๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐ :
๐ฆ๐ฒ๐ฝ๐๐ฒ๐บ๐ฏ๐ฒ๐ฟ ๐ฎ๐ฌ๐ฎ๐ฎ: YOURGENE HEALTH has obtained approval from the Health Sciences Authority (HSA) in Singapore for its IONA Nx NIPT Workflow, allowing it to be utilized in clinical laboratories. This approval signifies the regulatory endorsement for the use of their non-invasive prenatal testing technology, enabling healthcare providers to offer this advanced screening option to expectant parents in Singapore.
๐ง๐ผ๐ฝ ๐ฐ๐ผ๐บ๐ฝ๐ป๐ถ๐ฒ๐ ๐ถ๐ป ๐๐ต๐ฒ ๐ป๐ผ๐ป-๐ถ๐ป๐๐ฎ๐๐ถ๐๐ฒ ๐ฝ๐ฟ๐ฒ๐ป๐ฎ๐๐ฎ๐น ๐๐ฒ๐๐๐ถ๐ป๐ด (๐ก๐๐ฃ๐ง) ๐บ๐ฎ๐ฟ๐ธ๐ฒ๐:
โข Illumina, Inc
โข YOURGENE HEALTH (U.K.)
โข Natera (US)
โข Hoffmann-La Roche Ltd (Switzerland)
โข PerkinElmer Inc. (US)
โข Laboratory Corporation of America (US)
โข Eurofins LifeCodexx GmbH (Germany)
๐ฆ๐ฒ๐ด๐บ๐ฒ๐ป๐๐ :
The non-invasive prenatal testing (NIPT) market can be segmented into several key categories: product, technology, end user, and region. Each segment plays a crucial role in the overall growth and dynamics of the market.
๐๐ ๐ฃ๐ฟ๐ผ๐ฑ๐๐ฐ๐: The NIPT market can be divided into various products, including test kits and services. Test kits typically involve comprehensive testing kits provided by manufacturers, which include all necessary components for conducting NIPT in clinical settings. Services encompass laboratory testing services offered by specialized companies that perform genetic analysis and provide results to healthcare providers. This segmentation highlights the distinction between tangible products used for testing and the service-oriented aspect of the market.
๐๐ ๐ง๐ฒ๐ฐ๐ต๐ป๐ผ๐น๐ผ๐ด๐: The technology segment of the NIPT market includes various methodologies employed for testing. The most common technologies include next-generation sequencing (NGS) and polymerase chain reaction (PCR). NGS allows for comprehensive analysis of fetal DNA, enabling the detection of a wide range of chromosomal abnormalities with high accuracy. PCR, while less commonly used in NIPT, may also be utilized for specific applications. This segmentation emphasizes the technological advancements driving the efficiency and reliability of NIPT.
๐๐ ๐๐ป๐ฑ ๐จ๐๐ฒ๐ฟ: The end-user segment comprises hospitals, diagnostic laboratories, and other healthcare facilities that offer NIPT services. Hospitals often provide prenatal testing as part of comprehensive maternal care, while diagnostic laboratories focus on specialized testing services. Other healthcare facilities, such as fertility clinics and genetic counseling centers, also play a significant role in delivering NIPT services. This segmentation reflects the diverse settings where NIPT is utilized and the varying needs of different healthcare providers.
๐๐ ๐ฅ๐ฒ๐ด๐ถ๐ผ๐ป: The NIPT market can be further segmented by region, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Each region presents unique market dynamics influenced by factors such as regulatory frameworks, healthcare infrastructure, and the prevalence of prenatal testing practices. For instance, North America has a well-established NIPT market driven by advanced healthcare facilities and high awareness levels among expectant parents. In contrast, the Asia-Pacific region is witnessing rapid growth due to increasing healthcare access and rising demand for advanced prenatal screening options.
๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐๐ผ๐๐ฒ๐ฟ๐ฎ๐ด๐ฒ :
The report has studied the market in depth and underlined several crucial aspects and leading market participants. It provides important insights into the recent market trends and key industry developments. In addition to the factors mentioned above, the report covers many other factors that have helped the market grow.
๐๐ผ๐ฟ ๐๐๐น๐น ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐๐ผ๐๐ฒ๐ฟ๐ฎ๐ด๐ฒ ๐ฉ๐ถ๐๐ถ๐ : https://www.fortunebusinessinsights.com/industry-reports/non-invasive-prenatal-testing-market-100998
๐๐ฟ๐ถ๐๐ฒ๐ฟ๐ ๐ฎ๐ป๐ฑ ๐ฅ๐ฒ๐๐๐ฟ๐ฎ๐ถ๐ป๐๐ :
The Non-invasive Prenatal Testing (NIPT) market is driven by several factors, including the rising prevalence of chromosomal abnormalities, increased maternal age, and growing awareness of prenatal health among expectant parents. The technology's accuracy, safety, and ability to provide early results without the risk of miscarriage associated with invasive procedures further bolster its adoption. However, the market also faces certain restraints, such as high costs associated with NIPT, limited access in certain regions, and regulatory challenges that can hinder widespread implementation. Additionally, ethical considerations surrounding prenatal testing and potential misinformation regarding results may impact consumer trust and uptake.
๐ฅ๐ฒ๐ด๐ถ๐ผ๐ป๐ฎ๐น ๐๐ป๐๐ถ๐ด๐ต๐๐ :
The Non-invasive Prenatal Testing (NIPT) market shows significant regional insights, with North America leading due to high awareness levels, advanced healthcare infrastructure, and favorable reimbursement policies. Europe follows closely, driven by increasing adoption among healthcare professionals and growing demand for early prenatal testing. The Asia-Pacific region is witnessing rapid growth as maternal healthcare awareness rises, alongside an increase in healthcare expenditure and technological advancements. However, market penetration varies widely within regions, influenced by factors such as cultural attitudes toward prenatal testing, access to healthcare services, and regulatory environments. Latin America and the Middle East and Africa are emerging markets, showing potential for growth as healthcare systems evolve and NIPT becomes more accessible.
๐๐ผ๐บ๐ฝ๐ฒ๐๐ถ๐๐ถ๐๐ฒ ๐๐ฎ๐ป๐ฑ๐๐ฐ๐ฎ๐ฝ๐ฒ :
The competitive landscape of the Non-invasive Prenatal Testing (NIPT) market is characterized by a mix of established players and emerging companies, all striving to enhance their market position through innovation and strategic partnerships. Key players, such as Illumina, Natera, and Roche, dominate the market by leveraging advanced technologies and expanding their product offerings to include various genetic testing solutions. These companies invest significantly in research and development to improve the accuracy and scope of NIPT. Emerging players are focusing on niche markets and novel testing methodologies to differentiate themselves. The competitive dynamics are also influenced by factors such as pricing strategies, regulatory approvals, and collaborations with healthcare providers to facilitate broader adoption of NIPT services. Overall, the landscape is dynamic, with ongoing developments aimed at improving prenatal care and expanding access to testing.
๐๐๐๐๐ผ๐บ๐ถ๐๐ฒ ๐๐ต๐ถ๐ ๐ฟ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐ฎ๐ฐ๐ฐ๐ผ๐ฟ๐ฑ๐ถ๐ป๐ด ๐๐ผ ๐๐ผ๐๐ฟ ๐ฐ๐ผ๐ป๐๐ฒ๐ป๐ถ๐ฒ๐ป๐ฐ๐ฒ: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/non-invasive-prenatal-testing-market-100998
Contact Us:
Fortune Business Insightsโข Pvt. Ltd.
9th Floor, Icon Tower,
Baner, Pune-411045,
Maharashtra, India.
Phone:
U.S.: US +1 833 909 2966 (Toll Free)
UK +44 808 502 0280 (Toll Free)
APAC +91 744 740 1245
Email: sales@fortunebusinessinsights.com
About Us:
Fortune Business Insightsโข offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-invasive prenatal testing (NIPT) Market Size, Growth, Opportunities 2024-2032 | Illumina, Inc, YOURGENE HEALTH, Natera, Hoffmann-La Roche Ltd, PerkinElmer Inc., Laboratory Corporation of America, Eurofins LifeCodexx GmbH here
News-ID: 3677686 • Views: โฆ
More Releases from Fortune Business Insights

Organic Foods Market Poised for Remarkable Growth, set to Reach USD 529.64 billi โฆ
The global organic foods market was valued at USD 177.08 billion in 2023 and is anticipated to reach USD 199.35 billion in 2024, eventually growing to USD 529.64 billion by 2032. This growth reflects a compound annual growth rate (CAGR) of 12.99% during the forecast period. In 2023, Europe led the global organic foods market, accounting for 44.17% of the market share.
The organic food market in the United States isโฆ

Flavors and Fragrances Market Poised for Remarkable Growth, set to Reach USD 42. โฆ
The global flavors and fragrances market was valued at USD 27.50 billion in 2023 and is expected to grow to USD 42.27 billion by 2032, rising from USD 28.72 billion in 2024. This growth reflects a CAGR of 5.0% over the forecast period.
The market is anticipated to grow during the projected period due to rapid development in the pharmaceuticals and cosmetics sector. Fortune Business InsightsTM publishes this information inโฆ

Microalgae Market Poised for Remarkable Growth, set to Reach USD 1,376.42 millio โฆ
The global microalgae market was valued at USD 782.59 million in 2024 and is expected to grow to USD 841.30 million in 2025, reaching USD 1,376.42 million by 2032 at a CAGR of 7.29% over the forecast period. In 2024, North America led the market, holding a 37.2% share.
In the United States, the microalgae market is anticipated to reach USD 373.07 million by 2032, largely due to its growing useโฆ

Luxury Packaging Market Poised for Remarkable Growth, set to Reach USD 28.23 bil โฆ
The global luxury packaging market size was valued at USD 17.98 billion in 2023 and is expected to be worth USD 18.79 billion in 2024. The market is projected to reach USD 28.23 billion by 2032, recording a CAGR of 5.22% during the forecast period.
Luxury packaging is a state-of-the-art style of packaging that increases the overall visual appeal of a product and also helps companies improve their brand image. Severalโฆ
More Releases for NIPT
Non-Invasive Prenatal Testing Market has been analyzed from 2 viewpoints: NIPT T โฆ
Worldwide Market Reports recently released โGlobal Non-Invasive Prenatal Testing Market Research Report 2017โ that centers around the latest developing trends and technologies in the Non-Invasive Prenatal Testing Market having Five Years of forecast period from 2017 to 2022 and considering Market status study from 2017 to 2022.
During the research, noteworthy data was collected in order to shape the research document and make it a valuable resource for managers, industry executivesโฆ
United States Non-Invasive Prenatal Testing (NIPT) Market 2023
United States Non-Invasive Prenatal Testing (NIPT) Industry
United States Non-Invasive Prenatal Testing (NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023.
Latest Report on Non-Invasive Prenatal Testing (NIPT) Market United States Analysis & 2023 Forecast Research Study
Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no riskโฆ
China $1.7 NIPT Test Market Outlook 2017-2024
China Potential NonโInvasive Prenatal Testing (NIPT) market is likely to reach more than US$ 1.7 Billion by 2024.
Longโterm Growth Projection and Development:
โข It is predicted that China Actual NIPT test volume will increase to 1.6 Million by 2024
โข More than 3,00,000 NIFTY tests done in 2016
โข Berry Genomics completes US$ 648 Million reverse merger in Shenzhen
โข TwoโChild policy is likely to boost China NIPT market
Growth in China NIPT market canโฆ
2017 - 2021 : NIPT Test Market & Forecast
The Potential Non-Invasive Prenatal Testing(NIPT) Market is expected to reach more than USD 4 Billion across the 15 major markets(15MM) by the year end of 2021.
Buy Now @: www.dpiresearch.com/report-details.php?P_ID=93
Longโterm Growth Projection:
More than 2.5 Million tests will be conducted by the 11 major NIPT test by the year end of 2021.
Non-Invasive Prenatal Testing (NIPT) market size was valued at nearly USD 1 Billion in 2016 and market is expected to growโฆ
2017-2023 : US NIPT Test Market
United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023.
Buy Now @ http://www.dpiresearch.com/report-details.php?P_ID=100
Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch ofโฆ
Indian NIPT Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title Indian NIPT Market Outlook 2022 to its growing collection of premium market research reports.
NIPT helps obstetricians and pregnant women over different age-groups to better manage their pregnancy at a very early stage. Over the last few years, an increasing number of women in Tier-1 cities in India are giving preference to their career, and are opting for childbearing at aโฆ